Article Versions Notes

Miyake M, Hori S, Itami Y, Oda Y, Owari T, Fujii T, Ohnishi S, Morizawa Y, Gotoh D, Nakai Y, et al. Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model. Cancers. 2020; 12(7):1942. https://doi.org/10.3390/cancers12071942

Miyake, Makito, Shunta Hori, Yoshitaka Itami, Yuki Oda, Takuya Owari, Tomomi Fujii, Sayuri Ohnishi, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, and et al. 2020. "Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model" Cancers 12, no. 7: 1942. https://doi.org/10.3390/cancers12071942

Miyake, M., Hori, S., Itami, Y., Oda, Y., Owari, T., Fujii, T., Ohnishi, S., Morizawa, Y., Gotoh, D., Nakai, Y., Anai, S., Torimoto, K., Tanaka, N., & Fujimoto, K. (2020). Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model. Cancers, 12(7), 1942. https://doi.org/10.3390/cancers12071942